schizophrenia
Conditions
Interventions
None listed
Sponsors
Hokkaido university
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with schizophrenia 1. patients diagnosed with schizophrenia according to DSM-5 criteria 2. clinically stable patients 3. have the ability to speak Japanese adequately 4. Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study. Healty participant 1. have the ability to speak Japanese adequately 2. Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study.
Exclusion criteria
Exclusion criteria: 1. Subjects with a history of neurological disease with organic abnormalities in the central nervous system. 2. Subjects with serious cardiovascular, respiratory, gastrointestinal, renal, endocrine, or other diseases, or those with a history of such diseases that the investigator (subinvestigator) determines to be inappropriate as a research subject. 3. Subjects with coexisting diseases related to visual or hearing impairment. 4. Subjects who are judged by the principal investigator to be inappropriate as research subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Behavioral performance of tablet version of the cognitive function test to be developed. | — |
Secondary
| Measure | Time frame |
|---|---|
| Behavioral performance of the MCCB(MATRICS Consensus Cognitive Battery), an existing cognitive function test | — |
Countries
Japan
Contacts
Public ContactAtsuhito Toyomaki
Department of Psychiatry Hokkaido university
Outcome results
None listed